Home Overview Press Room Blog Publications For Students about us
Search

About Genetic Selection


Genetic selection procedures are done either on fetuses, through prenatal screening, or on embryos that are outside a woman’s body, through Preimplantation Genetic Diagnosis (PGD).

PGD tests embryos for the presence of genetic sequences linked to a variety of conditions and characteristics. A cell is extracted from an embryo at its eight-cell stage and analyzed. Embryos with the selected characteristics can be implanted in a woman's uterus to develop into a child. The procedure does not appear to affect embryos’ or fetuses’ subsequent development, though more follow-up studies of children born after PGD are needed.


Frequently Asked Questions

Arguments Pro & Con

PGD was developed to allow couples at risk of passing on a serious genetic disease to have children not affected by it. Since its introduction in 1990, it has been most widely used to prevent the birth of children with conditions such as Down's syndrome, Tay-Sachs disease, cystic fibrosis, sickle cell, Huntington's chorea, and Cooley's anemia.

However, PGD is increasingly being used for other reasons. These include social sex selection, creating “savior siblings” who can provide bone marrow or other transplant tissues to sick older siblings, and selecting against embryos with genes correlated with late-onset and non-fatal conditions. Some clinics have even offered the technique for purely cosmetic traits including eye color, hair color, and skin complexion.

A newer variation of PGD, called Preimplantation Genetic Haplotyping, allows for many more genes to be tested, and for greater accuracy.

Many disability rights advocates, in particular, have been critical of PGD and prenatal screening. They point out that the definition of "disease" is to some extent subjective. Most support women’s right to decide whether or not to have a child at a given time, but are critical of basing this decision on the traits of the particular embryo or fetus.



BREAKING THE WALL BETWEEN GENE SCIENCE AND ETHICS. How Philosophy Can Provide Frameworks for a Global Biotech Revolutionby Françoise BaylisFalling WallsDecember 2nd, 2016At Falling Walls, Françoise reflects on the immense opportunities and threats posed by next-generation biotechnologies and provides clues on how we, as a species, should deal with them.
Human Gene Editing: A Timeline of CRISPR Cover StoriesWith recent gene editing tools, a number of high-profile media are featuring CRISPR on their covers and front pages. We gather highlights since early 2015, along with opinion polls, TV shows, and editorial board statements.
Should We Rewrite the Human Genome?by Alex HardingXconomyNovember 28th, 2016Critics worry that a synthetic human genome could be used in unethical ways. Unlike for clinical trials, there is no regulatory body for basic science research.
Review of Blame: A Novelby Abby Lippman, Biopolitical Times guest contributorNovember 28th, 2016Blame is especially important for those unfamiliar with the range of ethical, social, legal, and political issues raised by applications of what is learned in a lab. While a work of fiction, it is definitely not science-fiction
Obama’s Science Advisors Are Worried About Future CRISPR Terrorismby Daniel OberhausVICE MotherboardNovember 21st, 2016PCAST warn that under current legislation, there is no room for rapid response to threats and misuse, recommending improved biosurveillance as a solution.
Why the Deaf Community Fears President Trumpby Sara NovicVICENovember 18th, 2016According to his biographer, Trump subscribes to a racehorse theory of human development and the superiority of certain genes — an echo of eugenics.
DNA-editing breakthrough could fix 'broken genes' in the brain, delay ageing and cure incurable diseasesby Ian JohnstonThe Independent [UK]November 16th, 2016The technique allows DNA changes that have not previously been possible, modifying the genes of non-dividing cells in a living animal.
CRISPR gene-editing tested in a person for the first timeby David CyranoskiNature NewsNovember 15th, 2016A clinical trial in China used cells edited with CRISPR-Cas9 to treat a patient with lung cancer. Spectators anticipate a biomedical duel with US.
San Diego Scientists Help Develop New Twist On In Vitro Fertilizationby David WagnerKPBSNovember 10th, 2016The patent holder for a related "3-person IVF" technique reports new work with "polar body genome transfer." Some experts say none of these approaches have been proven safe.
Why We Need to Rethink Ethnicity-Based Genetic Testingby Shivani NazarethUS News & World ReportNovember 7th, 2016The problem with genetic tests that assume people exist in neat race and ethnicity categories is that it simply is not an accurate reflection of their ancestry.
Displaying 1-10 of 605  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760